Not yet recruitingNCT06298292

Acceptability/Tolerance of Protein Substitutes in Tablet Form for the Dietary Management of Rare Aminoacidopathies

Studying Tyrosinemia type 1

Last synced from ClinicalTrials.gov May 7, 2026

ℹ

Clinical trial records are synced from ClinicalTrials.gov through automated extraction.

Report missing data

Key facts

Sponsor: metaX Institut fuer Diatetik GmbH
Principal Investigator: Anita MacDonald, Professor
Birmingham Children´s Hospital
Intervention: Zero minis (range of protein substitutes in tablet form)(dietary_supplement)
Enrollment: 15 enrolled
Eligibility: 7-18 years · All sexes
Timeline: 2024 – 2026

Collaborators

Birmingham Women's and Children's NHS Foundation Trust · Great Ormond Street Hospital for Children NHS Foundation Trust

Primary source

Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.

Open NCT06298292 on ClinicalTrials.gov

← Back to all trials